NCT03812302View on ClinicalTrials.gov

Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Giant Cell Arteritis
Interventions
DIAGNOSTIC_TEST

68-Ga HA-DOTATATE PET/CT

See arm description.

Trial Locations (1)

T6G 2G3

University of Alberta, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT03812302 - Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA) | Biotech Hunter | Biotech Hunter